Antidepressant effect of Nigella sativa in stress-induced depression
Dheeraj Ahirwar1, Bharti Ahirwar2
1School of Pharmacy, Chouksey Engineering College, Bilaspur, (CG) India 495006
2Institute of Pharmacy, Guru Ghasidas Central University, Bilaspur (CG) India 495001
*Corresponding Author E-mail: dheeraj_ahirwar@rediffmail.com, ah_bharti@yahoo.com
ABSTRACT:
Nigella sativa (NS) and its seeds have a long history of folkloric uses in all traditional systems of medicines globally for the treatment of various ailments. Therefore, the exploration of the antidepressant activity of this plant is to be the main aim. Nigella sativa seed powder was extracted with alcohol for 3 h in soxhlet. The extract was concentrated in the rotatory evaporator under reduced pressure. DPPH, superoxide radical scavenging, nitric oxide radical scavenging assay, and ABTS assay were carried out for antioxidant activity. The antidepressant activity was performed in stressed mice followed by tail suspension, locomotor activity, and forced swim test. Results indicated the potential antidepressant effect of NS extract in stressed mice, exposed to 6 h immobilizations. Methylene blue and SB-203580 potentiated the effect of sub-doses of NS in stressed mice along with significant antioxidant properties. NS extract also significantly decreased plasma nitric oxide.Seed extract of NS may consider as a new herbal antioxidant and antidepressant agent.
KEYWORDS: Depression, Nigella sativa, nitric oxide, SB, methylene blue.
INTRODUCTION:
Recently, excessive nitric oxide production is characterized in depressed patients and iNOS inhibitors are effective in depression treatment [9]. Currently, various therapeutic drugs have been used to treat depression, but due to their severe side effects such as psychomotor impairment, potentiation of other central depressant drugs and dependence liability, their clinical uses are still limited. Therefore, there is a need to consider herbal therapies as an alternative therapy and search for new herbal therapeutic drugs for the treatment of depression has progressed constantly across the world. Traditionally, many medicinal plants have been used in the treatment of depression and yet many herbal drugs are unexplored. Therefore, in this research, our aim was to explore Nigella sativa to treat stress-mediated depression as well as to elucidate the underlying mechanism in laboratory animals.
MATERIALS AND METHODS:
Nigella sativa seeds were procured from Local market, Bilaspur (CG) India. A taxonomist at Central Council for Research in Ayurveda and Siddha, Bangalore, India has confirmed its authentication. Specimen (RRCBI/NS-11-17) was stored in the departmental herbarium for future reference and stored. Dried seed powder (80 g) was extracted with ethanol for 3hours in a Soxhlet apparatus. The extract (oily fraction) was concentrated under reduced pressure and stored for further study.
Antioxidant screening of extract
Various in vitro antioxidant models were selected for the study such as DPPH free radical scavenging assay [10], superoxide radical scavenging activity [11], nitric oxide radical scavenging assay [12], and ABTS radical scavenging assay [13].
Animals
Swiss albino mice (22–30 g) were employed in the study. Animals were housed under laboratory conditions with alternating light and dark cycles of 12 h each. They had free access to food and water ad libidum. The animals were acclimatized to the laboratory conditions before behavioral experiments. Animal Experiment was carried according to CPCSEA-IAEC standard and after their approval (SOP/IAEC/21/2017).
Experimental protocol
Animals were divided into different groups. All the animals were stressed before the commencement of the experiment and after treatment, all the animals were subjected to tail suspension test, forced swim test and locomotor activity (actophotometer). Animals of group I administered normal saline and treated as a control group. Group II animals were administered with normal saline at the onset of immobilization (6 h) and treated as immobilization group. Rats of group III were administered with Fluoxetine (15mg/kg, i.p) at the onset of immobilization. Group IV animals were treated with NS extract (50 mg/kg). Group V animals were treated with NS extract (100 mg /kg). Group VI animals were administered NS extract (200 mg/kg). Group VII was administered with MB (15mg/kg). Group VIII animals were treated with MB + NS extract (15+100). Rats of group IX were treated with MB + NS extract (15+200). Group X animals were administered SB (1mg/kg). Group XI animals administered SB + NS extract (1+100). Group XII was treated with SB + NS extract (1+200).
Statistical analysis
All statistical analysis has been done using one-way analysis of variance (ANOVA) followed by Tukey’s test in the Graph Pad Instat (GPIS) package, version 3.05.
RESULTS AND DISCUSSION:
Data on table 1 revealed significant antioxidant activity of NS extract.
The potential antidepressant effect of Nigella sativa extract was found in stressed mice, exposed to 6 h immobilization. cGMP inhibitor MB is a downstream component of nitric oxide (NO) signaling pathway potentiated the sub-effective dose of NS extract. Further, p38MAPkinase inhibitor SB-203580 was also observed to enhance the effect of NS extract (Table 2).
Table 1 Antioxidant activity of NS extract
|
Concentration (mg/mL) |
% Inhibition on DPPH Radical |
% Inhibition on Superoxide Radical |
(% Inhibition) on Nitric oxide Radical |
(% Inhibition) on ABTS Radical |
|
NS |
NS |
NS |
NS |
|
|
50 |
10.00 |
14.03 |
13.63 |
19.37 |
|
100 |
12.12 |
15.26 |
21.51 |
27.68 |
|
200 |
16.18 |
46.18 |
39.76 |
46.69 |
|
300 |
66.16 |
58.88 |
53.24 |
59.31 |
|
400 |
71.12 |
65.28 |
62.82 |
71.25 |
|
500 |
89.26 |
70.17 |
72.54 |
84.18 |
|
IC 50 (mg/mL) |
226.72 |
254.75 |
281.74 |
214.78 |
NS = Nigella sativa
Table 2: The effect of different treatments on Immobility.
|
Treatment |
Dose (mg/kg, i.p.) |
Immobility time (sec) |
||
|
FST |
TST |
LMA |
||
|
IM |
6h |
215 ± 11.3 |
234.2 ± 12.3 |
156.1 ± 13.0 |
|
FLU |
15 |
125.4 ± 8.8a |
154.4 ± 8.8a |
137.1 ± 16 |
|
Extract |
5 |
182.0 ± 10.5 |
192.3 ± 16.5 |
154.3 ± 15 |
|
EXTRACT |
10 |
164.0 ± 7.8 |
185.2 ± 10.8 |
137.5 ± 11 |
|
EXTRACT |
20 |
121.2 ± 9.3b |
148.0 ± 15.3b |
119.2 ± 10 |
|
MB |
15 |
202.5 ± 13.9 |
236.7 ± 11.9 |
149.3 ± 19.6 |
|
MB + EXTRACT |
15+10 |
104.3 ± 11.8c |
125.4 ± 14.2c |
138.5 ± 16.7 |
|
MB + EXTRACT |
15+20 |
64.8 ± 15.3d |
87.0 ± 7.3d |
159.3 ± 15.8 |
|
SB |
1 |
128.9 ± 10.4e |
164.2 ± 13.4 e |
141.6 ± 10 |
|
SB + EXTRACT |
1+10 |
98.7 ± 12.8f |
119.2 ± 8.1f |
155.3 ± 14 |
|
SB + EXTRACT |
1+20 |
59.7 ± 14.7g |
74.1 ± 11.2g |
143.8 ± 18.5 |
IM = Immobilization, FLU = Fluoxetine, MB = Methylene blue, SB = SB - 203580.
Values are expressed as Mean ± S.E, p < 0.0001, a = p < 0.001 significant difference from immobilized group, b = p < 0.001 significant difference from immobilized group, c = p < 0.05 significant difference from EXTRACT (10 mg/kg) treated group, d = p < 0.05 significant difference from extract (20 mg/kg) treated group, e = p < 0.001 significant from immobilized group, f = p < 0.05 significant from extract (10 mg/kg) treated group, g = p < 0.05significant from extract (20 mg/kg) treated group.
It is a well-known fact that SB-203580 is an upstream element of iNOS formation in and after stress. Immobilization is the combination of emotional and physiological stress and directly involve in stress while painful stimuli is not directly involved [14]. Stress induces the release of a series of macromolecules cascades and elevated nitric oxide is one of the major contributors in stress-induced depression [15]. It is well documented that within 6 h immobilization activates the release of TNF- α via activation of NF-kappa B [16]. TNF-α plays a crucial role to activate the mitogen, and protein kinase pathways (MAPK) p42/p44 MAPK, JNK/SAPK, and p38 activated by mitogen, and p38 is responsible for interleukin-6 production [17]. Thus, it is hypothesized that immobilization-induced stress or depression involved inactivation of p38 MAPkinase and as a result increased the immobility duration and induce the symptoms of depression in the behavioral model [18]. Fluoxetine is selective serotonin reuptake inhibitors that blocked the reuptake of serotonin, resulted in increased extracellular serotonin concentrations in brain which exert an antidepressant effect. In comparison with the stress control group, fluoxetine significantly decreased the attack of depression frequency support the hypothesis that NOS inhibitors can be a new class of antidepressant drugs that may act on neuronal NOS [19]. Further, NOS inhibitors may exert their effect on enzyme level without affecting any changes in cellular biochemistry and dependency. Within 2 h stress has been reported to activate NOS which produced anxiety in rodents [18]. In the nitric oxide overproduction along with enhancing cytokine, glutamate level in stress induced by so many factors through NFκB activation [20]. NS extract significantly decreased plasma nitrite in immobilization-induced stressed mice group may be inhibiting iNOS mRNA expression. Similarly, SB-203580 treated group showed decreased plasma nitrite levels and produced an antidepressant effect (Table 3).
cGMP is a second messenger in neuronal cell–cell communication and in cell–cell signaling from between presynaptic fibers as well as between postsynaptic structures [21]. In the present study, MB significantly enhanced the antidepressant effect of Nigella sativa extract (NS) in stressed mice by influencing the NO–cGMP signaling pathway, thereby, preventing the further downstream signaling of nitrergic stimulus induced by immobilization stress [22]. None of the treatments produced any significant effect on locomotor activity.
Table 3: The effect of different treatments on plasma nitrite levels (µmol/L).
|
Treatment |
Dose (mg/kg, i.p) |
Number of animals |
Plasma nitrite levels (µmol/L) (Mean ± SEM) |
|
IM |
6h |
6 |
24.2 ± 1.8 |
|
FLU |
15 |
6 |
13.1 ± 1.5a |
|
EXTRACT |
5 |
6 |
20.6 ± 1.8 |
|
EXTRACT |
10 |
6 |
17.5 ± 1.6 |
|
EXTRACT |
20 |
6 |
14.8 ± 1.1b |
|
MB |
15 |
6 |
16.7 ± 1.7 |
|
MB + EXTRACT |
15+10 |
6 |
9.7 ± 2.2c |
|
MB + EXTRACT |
15+20 |
6 |
7.0 ± 1.8d |
|
SB |
1 |
6 |
11.3 ± 1.5e |
|
SB + EXTRACT |
1+10 |
6 |
8.4 ± 1.4f |
|
SB + EXTRACT |
1+20 |
6 |
6.7 ± 1.1g |
IM = Immobilization, FLU = Fluoxetine, MB = Methylene blue, SB = SB-203580.
Values are expressed as Mean ± S.E, p < 0.0001, a = p < 0.001 significant difference from immobilized group, b = p < 0.01 significant difference from immobilized group, c = p < 0.05 significant difference from extract (10 mg/kg) treated group, d = p < 0.05 significant difference from extract (20 mg/kg) treated group, e = p < 0.001 significant from immobilized group, f = p < 0.05 significant from extract (10 mg/kg) treated group, g = p < 0.05significant from extract (20 mg/kg) treated group.
Table 4: The effect of vehicle and immobilization on total immobility time. Values expressed in mean ± S.E. p = 0.0003. Veh: vehicle, IMMO: immobilization.
|
Dose |
Immobility time (sec) in FST |
Immobility time (sec) in TST |
Immobility time (sec) in LMA |
Plasma nitrite level (µmol/L |
|
Veh 10 ml/kg |
144.75 ± 7.2 |
188.5 ± 10.6 |
327.6 ± 15.3 |
14.3 ± 1.1 |
|
IM 6h |
215.9 ± 11.3 |
234.2 ± 12.3 |
156.1 ± 13.0 |
24.2 ± 1.8 |
Further, NS significantly influence plasma nitrite levels (Table 4), an indicator of NO production in depression, which further exerts their action on depression symptoms rather than on locomotor aspect involved in the behavior of mice in both the behavioral paradigms used in the present study.
CONCLUSION:
The present study was designed to investigate the possible effect of Nigella sativa, in mice under stressed conditions. Administration of Nigella sativa extract decreases the immobility time as well as plasma nitrite levels. MB and SB-203580 enhance the effect of Nigella sativa extract in stressed mice suggested NS is a good herbal antidepressant and antioxidant drug.
ACKNOWLEDGMENT:
The authors are thankful to Science and Engineering Research Board, New Delhi, India (SB/EMEQ-325/2014) for financial support.
REFERENCES:
1. Andreazza, A.C. Cassini, C. Rosa, A.R. Leite, M.C. De Almeida, L.M. Nardin, P. Cunha, A.B. Cereser, K.M. Santin, A. Gottfried, C. Salvodor, M. Kapczinski, F. Goncalves, C.A. Serum S100B and antioxidant enzymes in bipolar patients, J. Psychiatr. Res. 41:6 (2007) 523 - 529.
2. Andreazza, A.C. Kauer-Sant Anna, M. Frey, B.N. Stertz, L. Zanotto, C. Ribeiro, L. Giasson, K. Valvassori, S.S. Reus, G.Z. Salvador, M. Quevedo, J. Goncalves, C.A. Kapczinski, F. Effects of mood stabilizers on DNA damage in an animal model of mania, J. Psychiatry. Neurosci. 33:6 (2008) 516 - 524.
3. Halliwell, B. Biochemistry of oxidative stress, Biochem. Soc. Trans. 35:5 (2007) 1147 - 1150.
4. Gutteridge, J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage, Clin. Chem. 41:12 (1995) 1819 - 1828.
5. Niki, E. Yoshida, Y. Saito, Y. Noguchi, N. Lipid peroxidation: mechanism, inhibition, and biological effects, Biochem. Biophys. Res. Commun. 338:1 (2005) 668 - 676.
6. Bilici, M. Efe, H. Koroglu, M.A. Uydu, H.A. Bekaroglu, M. Deger, O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments, J. Affect. Disord. 64:1 (2001) 43 - 51.
7. Brookes, P.S. Yoon, Y. Robotham, J.L. Anders, M.W. Sheu, S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle, Am. J. Physiol. Cell Physiol. 287:4 (2004) 817 - 833.
8. Guzik, T.J. Korbut, R. Adamek-Guzik, T. Nitric oxide and superoxide in inflammation and immune regulation, J. Physiol. Pharmacol. 54:4 (2003) 469 - 487.
9. Galecki, P. Smigielski, J. Florkowski, A. Bobinska, K. Pietras, T. Szemrai, J. Analysis of two polymorphisms of the manganese superoxide dismutase gene (lle-58Thr and Ala-9Val) in patients with recurrent depressive disorder, Psychiatry Res. 179:1 (2010) 43 - 46.
10. Vani, T. Rajani, M. Sarkar, S. Shishoo, C.J. Antioxidant properties of the Ayurvedic formulation triphala and its constituents, Inter. J. Pharmacog. 35:5 (1997) 313 - 317.
11. Gow-Chin, Y. Hui-Yin, C. Antioxidant activity of various tea extracts in relation to their antimutagenicity, J. Agric. Food Chem. 43 (1995) 27 - 32.
12. Sreejavan, Rao, M.N. Oxide scavenging by curcuminoids, J. Pharm. Pharmacol. 49:1 (1997) 105 - 107.
13. Ahirwar, B. Ahirwar, D. Antioxidant and hepatoprotective activity of root extract of Baliospermum montanum (Wild) Muell Arg, RJPT. 12:6 (2019) 2705-2711.
14. Bhattacharya, S.K. and Bhattachatyya, D. Effect of restraint stress on rat brain serotonin, J. Biosci. 4 (1982) 269.
15. Esch, T. Stefano, G.B. Fricchione, G.L. Benson, H. The role of stress in neurodegenerative diseases and mental disorders, Neuroendocrinology Letters 22:3 (2002) 199 - 208.
16. Madrigal, J.L. Hurtado, O. Moro, M.A. Lizasoain, I. Lorenzo, P. Castrillo, A. Boscá, L. Leza, J.C. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress, Neuropsychopharmacology 26:2 (2002) 155 - 163.
17. Cesaris, M. Caillenz, H. Cadet, F. Pabion, M. In vivo analysis of HLA-DQ gene expression in heterozygous cell lines, Immunogentics 50 (1999) 309 - 318.
18. Sevgi, S. Ozek, M. Eroglu, L. L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress, Methods Find Exp. Clin. Pharmacol. 28:2 (2006) 95 - 99.
19. Mutlu, O. Ulak, G. Laugeray, A. Belzung, C. Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice, Pharmacol. Biochem. Behav. 92:1 (2009) 82 – 87.
20. Munhoz, C.D. García-Bueno, B.J.L. Madrigal, L.B. Lepsch, C. Scavone, J.C. Stress-induced neuroinflammation:mechanisms and new pharmacological Targets, Braz. J. Med. Biol. Res. 41:12 (2008) 1037 - 1046.
21. Southam, E. Garthwaile, J. The nitric oxide-cycle GMP signaling pathway in rat brain, Neuropharmacology 32:11 (1993) 1267 - 1277.
22. Eroglu, L. Caglayan, B. Anxiolytic and antidepressant properties of methylene blue in animal models, Pharmacol. Res. 36:5 (1997) 381 - 385.
Received on 18.12.2019 Modified on 10.02.2020
Accepted on 20.03.2020 © RJPT All right reserved
Research J. Pharm. and Tech. 2020; 13(4):1611-1614.
DOI: 10.5958/0974-360X.2020.00291.7